A New Way to Prevent Colon Cancer: A Conversation with Check-Cap's Yoav Kimchy, Ph.D.
Apr 26, 2021 ·
40m 24s
In this edition of The Onco’Zine Brief Peter Hofland, Ph.D. talks with Yoav Kimchy, Ph.D. Kimchy has more than 20 years of experience in the development and management of innovative...
show more
In this edition of The Onco’Zine Brief Peter Hofland, Ph.D. talks with Yoav Kimchy, Ph.D.
Kimchy has more than 20 years of experience in the development and management of innovative medical device companies. He founded Check-Cap in 2005 and served as the company's Chief Technology Officer.
Check-Cap is a clinical-stage medical diagnostics company aiming to redefine colorectal cancer screening/ through the introduction of C-Scan®, the first patient-friendly preparation-free screening test to detect polyps before they may transform into colorectal cancer. The new screening technology is being designed to enable early intervention and cancer prevention.
The capsule-based screening technology is expected to significantly increase screening adherence worldwide, and help millions of people to stay healthy through preventive colorectal cancer screening.
The technology is based on an ultra-low-dose X-ray capsule, an integrated positioning, control, and recording system, as well as proprietary software to generate a 3D map of the inner lining of the colon as it travels naturally along the gastrointestinal tract.
One of the benefits of the technology is that it is non-invasive and requires no sedation. And unlike other capsule technologies, it requires no preparation, allowing the patients to continue their daily routine without interruption.
An important caveat is that the technology is not intended to replace a colonoscopy. In the program, Kimchy argues that at all times a positive result should be followed by colonoscopy.
About The Onco'Zine Brief
The Onco'Zine Brief is distributed in the United States via PRX (Public Radio Exchange). In the United Kingdom and Europe, the program is distributed via UK Health Radio (UKHR). And the program can be downloaded via most podcasts and streaming media services, including iTunes, Spotify, TuneIn, and iHeart Radio.
For more information about The Onco'Zine Brief or how to sponsor or support this public radio broadcast and podcast, visit: https://www.patreon.com/theoncozinebrief
For more information about cancer and cancer treatments, visit our online journal Onco'Zine at www.oncozine.com
To sign up for The Onco'Zine Newsletter (open for residents of the United States only), text the word CANCER to 66866.
show less
Kimchy has more than 20 years of experience in the development and management of innovative medical device companies. He founded Check-Cap in 2005 and served as the company's Chief Technology Officer.
Check-Cap is a clinical-stage medical diagnostics company aiming to redefine colorectal cancer screening/ through the introduction of C-Scan®, the first patient-friendly preparation-free screening test to detect polyps before they may transform into colorectal cancer. The new screening technology is being designed to enable early intervention and cancer prevention.
The capsule-based screening technology is expected to significantly increase screening adherence worldwide, and help millions of people to stay healthy through preventive colorectal cancer screening.
The technology is based on an ultra-low-dose X-ray capsule, an integrated positioning, control, and recording system, as well as proprietary software to generate a 3D map of the inner lining of the colon as it travels naturally along the gastrointestinal tract.
One of the benefits of the technology is that it is non-invasive and requires no sedation. And unlike other capsule technologies, it requires no preparation, allowing the patients to continue their daily routine without interruption.
An important caveat is that the technology is not intended to replace a colonoscopy. In the program, Kimchy argues that at all times a positive result should be followed by colonoscopy.
About The Onco'Zine Brief
The Onco'Zine Brief is distributed in the United States via PRX (Public Radio Exchange). In the United Kingdom and Europe, the program is distributed via UK Health Radio (UKHR). And the program can be downloaded via most podcasts and streaming media services, including iTunes, Spotify, TuneIn, and iHeart Radio.
For more information about The Onco'Zine Brief or how to sponsor or support this public radio broadcast and podcast, visit: https://www.patreon.com/theoncozinebrief
For more information about cancer and cancer treatments, visit our online journal Onco'Zine at www.oncozine.com
To sign up for The Onco'Zine Newsletter (open for residents of the United States only), text the word CANCER to 66866.
Information
| Author | Peter Hofland |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
